The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
I asked Perplexity 'Does Avacta's affimer technology have applications in cancer therapeutics?'
Answers:
https://www.perplexity.ai/search/Does-Avactas-affimer-QEaVIUCMR66Ko_02dzOKHQ
Is anyone going to the evening meeting tomorrow? I expressed my interest in attending but no confirmation has come through. PR needs an upgrade
This cancer has proved a very tough nut to crack.
https://www.independent.co.uk/news/health/pancreatic-cancer-deaths-uk-b2510720.html
What any antibody can do, an affimer can do. Wonder what an affimer-based FAS kill switch activator could do. I expect it would blow the bloody doors off!
https://www.sciencealert.com/scientists-find-kill-switch-that-activates-cancer-cell-death-in-the-lab
Rare cancers taken together as a group are as important (diagnosed in similar numbers) as common cancers such as breast, prostate, colon, etc. The usefulness of established chemotherapy drugs is being studied, with improved outcomes observed
https://www.theguardian.com/science/2023/oct/14/patients-with-rare-cancers-given-hope-by-uk-led-drug-match-trial
Dr Greger is saying that the contribution of chemo to 5 year survival is a very small percentage, not that the overall 5 yr survival is 1 or 2%. His background is in public health in NYC
Answer: very weakly https://nutritionfacts.org/2022/07/14/how-effective-is-chemotherapy-for-colon-lung-breast-and-prostate-cancers/#:~:text=Although%20chemotherapy%20treatment%20is%20fairly,patients%2C%20only%20146%20live%20for
Squid News
Avacta could generate affimer candidates with the same functionality as this key antibody in as little time as they took creating new affimers to bind to the SARS-CoV-2 antigen - a matter of weeks as I recall
https://go.squidapp.co/n/eD6Ecrq?i=nbf888gD&r=1&t=n
Serious concerns about the Innova test raised by UK experts following FDA advice to "put them in the trash." The UK regulator gave a 2 month extension to its authorisation of the Innova test for home use AFTER the FDA disqualified it. Anybody know what has happened since then? Was a further 'temporary' authorisation granted to Innova? What a messhttps://blogs.bmj.com/bmj/2021/07/11/why-all-the-secrecy-around-innova-lateral-flow-tests/
Dog? OK just lately the volatile share price has made the company look like an aimless elephant. But huge progress has been made while the shares have been kicked around by traders. After 2 years Avacta is now a VERY different animal. Soon this elephant will be galloping, and fast